Evaluation of the impact of interferon-gamma release assays on the management of childhood tuberculosis

Pediatric Infectious Disease Journal

Volumn 31, Issue 12, 2012, Pages 1258-1262

  Ling, Daphne I ^a   Crépeau, Claire A ^b   Dufresne, Marieke ^b   Khan, Shazia ^b   Quach, Caroline ^a,b   Dendukuri, Nandini ^c   Schwartzman, Kevin ^a,d   Menzies, Dick ^a,d   Lands, Larry C ^b   Pai, Madhukar ^a,d  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Children; Diagnostics; Interferon gamma release assay; Latent tuberculosis infection; Tuberculosis

Indexed keywords

GAMMA INTERFERON; ISONIAZID; TUBERCULIN;

ADOLESCENT; ADULT; ARTICLE; BCG VACCINATION; CHILD; CHILDHOOD DISEASE; CLINICAL DECISION MAKING; CLINICAL EVALUATION; COHORT ANALYSIS; DIAGNOSTIC TEST; FEMALE; FOLLOW UP; HUMAN; IMMIGRANT; INFANT; INFECTION RISK; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL HISTORY; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONOLOGY; QUANTIFERON TB GOLD IN TUBE; SCHOOL CHILD; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON-GAMMA RELEASE TESTS; ISONIAZID; MALE; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84870911011     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318269d10c     Document Type: Article

References (19)

1. Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, et al. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J. 2011;30:694-700.
2. Mandalakas AM, Detjen AK, Hesseling AC, et al. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2011;15:1018-1032.
3. Denkinger CM, Dheda K, Pai M. Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect. 2011;17:806-814.
4. Canadian Tuberculosis Committee (CTC). Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). Can Commun Dis Rep. 2008;34(ACS-6):1-13.
5. Canadian Tuberculosis Committee (CTC). Recommendations on Interferon Gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection-2010 Update. An Advisory Committee Statement (ACS). Can Commun Dis Rep. 2010;36(ACS-5):1-22.
6. Kakkar F, Allen U, Ling D, et al. Tuberculosis in children: new diagnostic blood tests. Can J Infect Dis Med Microbiol. 2010;21:e111-e115.
7. Brassard P, Steensma C, Cadieux L, et al. Evaluation of a school-based tuberculosis-screening program and associate investigation targeting recently immigrated children in a low-burden country. Pediatrics. 2006;117:e148-e156.
8. Menzies D, Khan K. Diagnosis of tuberculosis infection and disease. In: Long R, Ellis E, eds. Canadian Tuberculosis Standards. 6th ed. Ottawa, ON: Government of Canada; 2007:53-91.
9. Zwerling A, Behr MA, Verma A, et al. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011;8:e1001012.
10. WHO. Global Tuberculosis Control. Geneva, Switzerland: World Health Organization; 2011.
11. Sun G W, Shook TL, Kay GL. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol. 1996;49:907-916.
12. UCLA. Academic Technology Services SCG. Analyzing Correlated (Clustered) Data. http://www.ats.ucla.edu/stat/stata/Library/cpsu.htm. Accessed April 4, 2012.
13. Cobelens F, van den Hof S, Pai M, et al; Evidence for Scale-up Group. Which new diagnostics for tuberculosis, and when? J Infect Dis. 2012;205(suppl 2):S191-S198.
14. Lijmer JG, Leeflang M, Bossuyt PM. Proposals for a phased evaluation of medical tests. Med Decis Making. 2009;29:E13-E21.
15. Al Zahrani K, Al Jahdali H, Menzies D. Does size matter? Utility of size of tuberculin reactions for the diagnosis of mycobacterial disease. Am J Respir Crit Care Med. 2000;162(4 pt 1):1419-1422.
16. Taylor RE, Cant AJ, Clark JE. Potential effect of NICE tuberculosis guidelines on paediatric tuberculosis screening. Arch Dis Child. 2008;93:200-203.
17. Kunimoto D, Der E, Beckon A, et al. Use of the QuantiFERON-TB Gold test to confirm latent tuberculosis infection in a Canadian tuberculosis clinic. Int J Tuberc Lung Dis. 2009;13:726-730.
18. Oxlade O, Schwartzman K, Menzies D. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. Int J Tuberc Lung Dis. 2007;11:16-26.
19. Rangaka MX, Wilkinson KA, Glynn JR, et al. Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:45-55.